Minimum radial margin in pelvic exenteration for locally advanced or recurrent rectal cancer
- PMID: 35768314
- DOI: 10.1016/j.ejso.2022.06.015
Minimum radial margin in pelvic exenteration for locally advanced or recurrent rectal cancer
Abstract
Purpose: The aim of this study was to clarify the suitable radial margin (RM) for favourable outcomes after pelvic exenteration (PE), focusing on the discrepancy between the concepts of circumferential resection margin (CRM) and traditional R status.
Methods: Seventy-three patients with locally advanced (LARC, n = 24) or locally recurrent rectal cancer (LRRC, n = 49) who underwent PE between 2006 and 2018 were retrospectively analysed. Patients were histologically classified into the following 3 groups; wide RM (≥1 mm, n = 45), narrow RM (0-1 mm, n = 10), and exposed RM (n = 18). The analysis was performed not only in the entire cohort but also in each disease group separately.
Results: The rates of traditional R0 (RM > 0 mm) and wide RM were 75.3% and 61.6%, respectively, resulting in the discrepancy rate of 13.7% between the two concepts. Preoperative radiotherapy was given in 12.3%. In the entire cohort, the local recurrence and overall survival (OS) rates for narrow RMs were significantly worse than those for wide RMs (p < 0.001 and p = 0.002), but were similar to those for exposed RMs. In both LARC and LRRC, RM < 1 mm resulted in significantly worse local recurrence and OS rates compared to the wide RMs. Multivariate analysis showed that RM < 1 mm was an independent risk factor for local recurrence in both LARC (HR 15.850, p = 0.015) and LRRC (HR 4.874, p = 0.005).
Conclusions: Narrow and exposed RMs had an almost equal impact on local recurrence and poor OS after PE. Preoperative radiotherapy might have a key role to ensure a wide RM.
Keywords: Circumferential resection margin; Locally advanced rectal cancer; Locally recurrent rectal cancer; Pelvic exenteration; Radial margin.
Copyright © 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no conflict of interest. Corresponding author Kay Uehara.
Similar articles
-
Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer.Eur J Surg Oncol. 2023 Nov;49(11):106971. doi: 10.1016/j.ejso.2023.06.023. Epub 2023 Jun 26. Eur J Surg Oncol. 2023. PMID: 37442715
-
Contemporary results from the PelvEx collaborative: improvements in surgical outcomes for locally advanced and recurrent rectal cancer.Colorectal Dis. 2024 May;26(5):926-931. doi: 10.1111/codi.16948. Epub 2024 Apr 2. Colorectal Dis. 2024. PMID: 38566456
-
Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.Eur J Surg Oncol. 2018 Oct;44(10):1548-1554. doi: 10.1016/j.ejso.2018.06.033. Epub 2018 Jul 20. Eur J Surg Oncol. 2018. PMID: 30075979
-
A systematic review of oncosurgical and quality of life outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer.Ann R Coll Surg Engl. 2025 Jan;107(1):2-11. doi: 10.1308/rcsann.2023.0031. Epub 2024 Feb 16. Ann R Coll Surg Engl. 2025. PMID: 38362800 Free PMC article.
-
Preoperative assessment and optimisation for pelvic exenteration in locally advanced and recurrent rectal cancer: A review.Eur J Surg Oncol. 2022 Nov;48(11):2250-2257. doi: 10.1016/j.ejso.2021.11.007. Epub 2021 Nov 11. Eur J Surg Oncol. 2022. PMID: 34922810 Review.
Cited by
-
Evaluating the short-term outcome of laparoscopic pelvic exenteration in locally advanced and recurrent rectal cancer.Surg Today. 2025 Jun 4. doi: 10.1007/s00595-025-03048-4. Online ahead of print. Surg Today. 2025. PMID: 40464924
-
A Novel Treatment Strategy for Unresectable Locally Recurrent Rectal Cancer-Upfront Carbon-Ion Radiotherapy Followed by Surgical Resection of the Irradiated Intestines.Cancers (Basel). 2025 Jul 3;17(13):2230. doi: 10.3390/cancers17132230. Cancers (Basel). 2025. PMID: 40647528 Free PMC article.
-
Intraoperative Radiation Therapy (IORT) in Gynecologic Cancers: A Scoping Review.Cancers (Basel). 2025 Apr 18;17(8):1356. doi: 10.3390/cancers17081356. Cancers (Basel). 2025. PMID: 40282536 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources